C16 Glucosyl<wbr/>ceramide-d<sub>3</sub> (d18:1/<wbr/>16:0-d<sub>3</sub>)

C16 Glucosylceramide-d3 (d18:1/16:0-d3)

CAT N°: 24621
Price:

733.00 623.05

C16 Glucosylceramide-d3 is intended for use as an internal standard for the quantification of C16 glucosylceramide by GC- or LC-MS. C16 glucosylceramide is an endogenous bioactive sphingolipid.{41488,41489} It is a precursor in the synthesis of C16 lactosylceramide (Item No. 24352) that is formed via metabolism of C16 ceramide (Item No. 10681) by glucosylceramide synthase.{41133} Inhalation of C16 glucosylceramide reduces lung colonization by P. aeruginosa and increases survival in a mouse model of cystic fibrosis.{41488} C16 Glucosylceramide levels are elevated in the plasma of Parkinson’s disease patients with cognitive impairments.{41489} As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1533]

We also advise you